Second surgical treatment of retroperitoneal persistent disease in epithelial ovarian cancer

Tumori

Volumn 82, Issue 1, 1996, Pages 81-84

  Lupi, Giovanni ^a   Fontanelli, Rosanna ^a   Jin, Rui ^a   Grosso, Giuseppe ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

lymphadenectomy; ovarian cancer

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; OVARY CARCINOMA; RETROPERITONEUM;

EID: 0029964094     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169608200118     Document Type: Article

References (13)

1. Burghardt E., Pickel H., Lahousen M., Stettner H.: Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am. J. Obstet. Gynecol., 155: 315-319, 1986.
2. Burghardt E., Winter, R.: The effect of chemotherapy on lymph node metastases in ovarian cancer. In: Clinical Obstetrics and Gynecology, Burghardt E., Monaghan J.M. (Eds.), Vol. 3, pp. 166-171, Bailliere Tindall, London, 1989.
3. Chen S.S.: Survival of ovarian carcinoma with or without lymph node metastasis. Gynecol. Oncol., 27: 368-372, 1987.
4. Di Re F., Fontanelli R., Raspagliesi F., Di Re E.: Pelvic and paraaortic lymphadenectomy in cancer of the ovary. In: Clinical Obstetrics and Gynecology, E. Burghardt E., Monaghan J.M. (Eds.), Vol. 3, pp. 131-142, Bailliere Tindall, London, 1989.
5. Di Re R, Fontanelli R.: Cancer of the ovary. In: Surgical Oncology, Veronesi U. (Ed.), pp. 768-782, Springer-Verlag, Berlin, Heidelberg, 1989.
6. Hacker N.F.: Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: therapeutic advance or surgical folly? Gynecol. Oncol., 56: 325-327, 1995.
7. Heintz A.P.M., Hacker N.F., Berek J.S., Rose T.P., Munoz A.K., Lagasse L.D.: Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity. Obstet. Gynecol., 67: 783-788, 1986.
8. Hoskins W.: The influence of cytoreductive surgery on progression-free interval and survival in epithelial ovarian cancer. In: Clinical Obstetrics and Gynecology, Burghardt E., Monaghan J.M. (Eds.), Vol. 3, pp. 59-71, Bailiiere Tindall, London, 1989.
9. Monaghan J.M.: Surgical techniques used in achieving optimal resection of stage III cancer of the ovaries. In; Clinical Obstetrics and Gynecology, Burghardt E., Monaghan J.M. (Eds.), Vol. 3, pp. 39-48, Bailiiere Tindall, London, 1989.
10. Podratz K.C., Malkasian G.D., Wieand H.S., Cha S.S., Lee R.A., Stanhope C.R., William T.J.: Recurrent disease after negative second look laparotomy in stages III and IV ovarian carcinoma. Gynecol. Oncol., 29: 274-282, 1988.
11. Scarabelli C., Gallo A., Zarrelli A., Visentin C., Campagnutta E.: Systematic pelvic and paraaortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival. Gynecol. Oncol., 56: 328-337, 1995.
12. Spirtos N.M., Gross G.M., Freddo J.L., Ballon S.C.: Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. Gynecol. Oncol., 56: 345-352, 1995.
13. Wu P.C., Qu J.Y., Lang J.H., Huang R.L., Tang M.Y., Lian L.J.: Lymph node metastasis of ovarian cancer: a preliminary surgery of 74 cases of lymphadenectomy. Am. J. Obstet. Gynecol., 155: 1103-1108, 1986.